# ORIAHNN (COPACKAGED)
> **NDA213388** · New Drug Application · Sponsor: ABBVIE · Approved 2020-05-29
## Drug
- **FDA Application Number:** NDA213388
- **Application type:** New Drug Application
- **Brand name:** ORIAHNN (COPACKAGED)
- **Generic name:** ELAGOLIX AND ESTRADIOL AND NORETHISTERONE
- **Active ingredients:** ELAGOLIX SODIUM,ESTRADIOL,NORETHINDRONE ACETATE; ELAGOLIX SODIUM
- **Dosage form:** CAPSULE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** ABBVIE
- **Manufacturer:** AbbVie Inc.
- **First approval:** 2020-05-29
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213388)
---
*AI Analytics · CC0 1.0*